Lifemd Inc Stock Analysis
LFMD Stock | USD 11.16 0.27 2.48% |
LifeMD Inc is overvalued with Real Value of 10.29 and Target Price of 7.75. The main objective of LifeMD stock analysis is to determine its intrinsic value, which is an estimate of what LifeMD Inc is worth, separate from its market price. There are two main types of LifeMD's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect LifeMD's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of LifeMD's stock to identify patterns and trends that may indicate its future price movements.
The LifeMD stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. LifeMD is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. LifeMD Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and LifeMD's ongoing operational relationships across important fundamental and technical indicators.
LifeMD |
LifeMD Stock Analysis Notes
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.7. LifeMD Inc last dividend was issued on the 14th of October 2020. The entity had 1:5 split on the 14th of October 2020. LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, mens sexual health, dermatology, and others in the United States. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. LifeMD operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 196 people. To find out more about LifeMD Inc contact Justin Schreiber at 866-351-5907 or learn more at https://lifemd.com.LifeMD Quarterly Total Revenue |
|
LifeMD Inc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. LifeMD's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding LifeMD Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
LifeMD Inc appears to be risky and price may revert if volatility continues | |
The company currently holds 18.93 M in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist LifeMD until it has trouble settling it off, either with new capital or with free cash flow. So, LifeMD's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LifeMD Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LifeMD to invest in growth at high rates of return. When we think about LifeMD's use of debt, we should always consider it together with cash and equity. | |
The entity reported the previous year's revenue of 152.55 M. Net Loss for the year was (20.6 M) with profit before overhead, payroll, taxes, and interest of 100.37 M. | |
LifeMD Inc has a frail financial position based on the latest SEC disclosures | |
About 20.0% of LifeMD outstanding shares are owned by corporate insiders | |
Latest headline from finance.yahoo.com: LifeMD to Participate in Upcoming Investor and Industry Conferences During May |
LifeMD Inc Upcoming and Recent Events
Earnings reports are used by LifeMD to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to LifeMD previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of March 2024 Upcoming Quarterly Report | View | |
10th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
LifeMD Largest EPS Surprises
Earnings surprises can significantly impact LifeMD's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-03-11 | 2023-12-31 | -0.14 | -0.12 | 0.02 | 14 | ||
2023-11-08 | 2023-09-30 | -0.15 | -0.2 | -0.05 | 33 | ||
2021-11-10 | 2021-09-30 | -0.62 | -0.54 | 0.08 | 12 |
LifeMD Thematic Classifications
In addition to having LifeMD stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
LifeMD Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as LifeMD is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LifeMD Inc backward and forwards among themselves. LifeMD's institutional investor refers to the entity that pools money to purchase LifeMD's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Qube Research & Technologies | 2023-12-31 | 337.6 K | Marshall Wace Asset Management Ltd | 2023-12-31 | 321.9 K | Geode Capital Management, Llc | 2023-12-31 | 292.1 K | Jane Street Group, Llc | 2023-12-31 | 224.3 K | Renaissance Technologies Corp | 2023-12-31 | 193.4 K | Boothbay Fund Management, Llc | 2023-12-31 | 186.2 K | Barry Investment Advisors, Llc | 2023-12-31 | 178.4 K | Point72 Asset Management, L.p. | 2023-09-30 | 172.2 K | Bank Of New York Mellon Corp | 2023-12-31 | 163.5 K | Divisadero Street Capital Management, Lp | 2023-12-31 | 1.8 M | Vanguard Group Inc | 2023-12-31 | 1 M |
LifeMD Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 425.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate LifeMD's market, we take the total number of its shares issued and multiply it by LifeMD's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.LifeMD Profitablity
LifeMD's profitability indicators refer to fundamental financial ratios that showcase LifeMD's ability to generate income relative to its revenue or operating costs. If, let's say, LifeMD is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, LifeMD's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of LifeMD's profitability requires more research than a typical breakdown of LifeMD's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.05) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.05. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.47) | (0.50) | |
Return On Capital Employed | (0.61) | (0.58) | |
Return On Assets | (0.35) | (0.37) | |
Return On Equity | (5.88) | (6.17) |
Management Efficiency
LifeMD Inc has return on total asset (ROA) of (0.2152) % which means that it has lost $0.2152 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.8248) %, meaning that it created substantial loss on money invested by shareholders. LifeMD's management efficiency ratios could be used to measure how well LifeMD manages its routine affairs as well as how well it operates its assets and liabilities. As of April 24, 2024, Return On Tangible Assets is expected to decline to -0.5. The current year's Return On Capital Employed is expected to grow to -0.58. At present, LifeMD's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 44.7 M, whereas Non Currrent Assets Other are forecasted to decline to (1.05).Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.10 | 0.06 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | (0.27) | (0.26) | |
Enterprise Value Over EBITDA | (33.83) | (32.14) | |
Price Book Value Ratio | 80.18 | 84.19 | |
Enterprise Value Multiple | (33.83) | (32.14) | |
Price Fair Value | 80.18 | 84.19 | |
Enterprise Value | 266.9 M | 280.2 M |
The analysis of LifeMD's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze LifeMD's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of LifeMD Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.425 |
Technical Drivers
As of the 24th of April, LifeMD secures the Downside Deviation of 3.62, mean deviation of 3.28, and Risk Adjusted Performance of 0.1563. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of LifeMD Inc, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have collected data for nineteen technical drivers for LifeMD, which can be compared to its peers in the industry. Please verify LifeMD Inc standard deviation, value at risk, kurtosis, as well as the relationship between the jensen alpha and semi variance to decide if LifeMD Inc is priced some-what accurately, providing market reflects its recent price of 11.16 per share. Given that LifeMD Inc has jensen alpha of 0.836, we recommend you to check LifeMD's last-minute market performance to make sure the company can sustain itself at a future point.LifeMD Inc Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. LifeMD middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for LifeMD Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
LifeMD Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LifeMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on LifeMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LifeMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
LifeMD Predictive Daily Indicators
LifeMD intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LifeMD stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
LifeMD Corporate Filings
F4 | 5th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 25th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
15th of March 2024 Other Reports | ViewVerify | |
F4 | 14th of March 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 11th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
13A | 14th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
21st of December 2023 Other Reports | ViewVerify | |
8K | 13th of December 2023 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
LifeMD Forecast Models
LifeMD's time-series forecasting models are one of many LifeMD's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary LifeMD's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About LifeMD Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how LifeMD prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling LifeMD shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as LifeMD. By using and applying LifeMD Stock analysis, traders can create a robust methodology for identifying LifeMD entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (0.11) | (0.12) | |
Operating Profit Margin | (0.09) | (0.1) | |
Net Loss | (0.14) | (0.14) | |
Gross Profit Margin | 0.83 | 0.61 |
Current LifeMD Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. LifeMD analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. LifeMD analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.75 | Strong Buy | 5 | Odds |
Most LifeMD analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand LifeMD stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of LifeMD Inc, talking to its executives and customers, or listening to LifeMD conference calls.
LifeMD Stock Analysis Indicators
LifeMD Inc stock analysis indicators help investors evaluate how LifeMD stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading LifeMD shares will generate the highest return on investment. By understating and applying LifeMD stock analysis, traders can identify LifeMD position entry and exit signals to maximize returns.
Begin Period Cash Flow | 4 M | |
Long Term Debt | 17.9 M | |
Common Stock Shares Outstanding | 33.9 M | |
Total Stockholder Equity | 3.5 M | |
Tax Provision | 428 K | |
Property Plant And Equipment Net | 1.1 M | |
Cash And Short Term Investments | 33.1 M | |
Cash | 33.1 M | |
Accounts Payable | 11.1 M | |
Net Debt | -14.2 M | |
50 Day M A | 9.0506 | |
Total Current Liabilities | 34.8 M | |
Other Operating Expenses | 167 M | |
Non Current Assets Total | 15.9 M | |
Forward Price Earnings | 32.1543 | |
Non Currrent Assets Other | -1.00 | |
Stock Based Compensation | 12.5 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for LifeMD Stock analysis
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is LifeMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 4.499 | Quarterly Revenue Growth 0.595 | Return On Assets (0.22) | Return On Equity (7.82) |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.